Drugs / Xueshuanxinmaining tablet
Xueshuanxinmaining tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04270279 | Dec 2020 → Aug 2021 | coronary artery disorder | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xueshuanxinmaining tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04270279 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Xueshuanxinmaining tablet is a Chinese patent medicine” NCT04270279 ↗ |
| Route | Oral | “Patients were given Xueshuanxinmaining tablet orally 2 pills each time” NCT04270279 ↗ |